Latanea

Latanoprost, the active ingredient in Latanea, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It lowers intra‑ocular pressure and is used in the management of glaucoma and ocular hypertension in adult patients.

GNH USA supplies Latanea as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost is employed in the prostaglandin analog class to reduce intra‑ocular pressure in several glaucoma‑related conditions. - Primary open‑angle glaucoma: reduces intra‑ocular pressure to slow disease progression. - Ocular hypertension: lowers eye pressure to prevent conversion to glaucoma. - Secondary open‑angle glaucoma (including pseudoexfoliative glaucoma): helps control pressure when other mechanisms are involved.

Latanoprost may cause ocular and peri‑ocular reactions, most of which are mild and reversible.

Common Side Effects: - Eye redness (hyperemia): mild conjunctival injection. - Increased iris pigmentation: gradual darkening of the iris. - Eyelash changes: longer, thicker, or darker lashes. - Ocular irritation: burning or stinging sensation. - Dry eye sensation: transient dryness or foreign body feeling.

Serious or Rare Side Effects: - Uveitis or iritis: inflammation of the uveal tract. - Macular edema: swelling of the central retina. - Iris or retinal cyst formation: rare proliferative lesions. - Severe allergic reaction: swelling, itching, or rash around the eye.

When prescribing latanoprost, clinicians should observe several safety considerations. - Monitor intra‑ocular pressure: assess response after initiation. - Evaluate ocular surface: check for pre‑existing inflammation or infection. - Avoid use in active ocular infection: postpone treatment until resolved. - Caution in patients with a history of herpetic keratitis: monitor for reactivation. - Discontinue if severe inflammation or macular edema develops: seek ophthalmologic evaluation. - Store at room temperature below 25 °C: keep in original container, protect from light and moisture.

Latanoprost can interact with other ocular or systemic agents, influencing efficacy or safety.

Major Interactions (Avoid): - Concomitant use with other prostaglandin analog eye drops: may increase risk of ocular hyperemia and pigmentation changes. - Use with topical non‑steroidal anti‑inflammatory drugs (NSAIDs): can exacerbate ocular irritation.

Moderate Interactions (Monitor Closely): - Combination with carbonic anhydrase inhibitors or beta‑blocker eye drops: additive intra‑ocular pressure‑lowering effect, monitor pressure closely. - Systemic use of immunosuppressants: may alter ocular healing response. - Anticholinergic agents: potential for reduced tear production, monitor for dry eye.